scholarly journals CD19 expression in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia pre‐ and post‐treatment with blinatumomab

2021 ◽  
Author(s):  
Ester Mejstrikova ◽  
Matthias Klinger ◽  
Ana Markovic ◽  
Gerhard Zugmaier ◽  
Franco Locatelli
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Pediatric Patients ◽  
Lymphoblastic Leukemia ◽  
Post Treatment ◽  
Cell Precursor ◽  
Cd19 Expression

scholarly journals Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

2018 ◽  
Vol 8 (9) ◽  
Author(s):  
Lia Gore ◽  
Franco Locatelli ◽  
Gerhard Zugmaier ◽  
Rupert Handgretinger ◽  
Maureen M. O’Brien ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Pediatric Patients ◽  
Lymphoblastic Leukemia ◽  
Cell Precursor

scholarly journals Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

Leukemia ◽  
2020 ◽  
Vol 34 (9) ◽  
pp. 2473-2478 ◽  
Author(s):  
Franco Locatelli ◽  
James A. Whitlock ◽  
Christina Peters ◽  
Christiane Chen-Santel ◽  
Victoria Chia ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Standard Therapy ◽  
Pediatric Patients ◽  
Lymphoblastic Leukemia ◽  
Cell Precursor

scholarly journals Blinatumomab in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia

2020 ◽  
Author(s):  
Manon Queudeville ◽  
Patrick Schlegel ◽  
Amadeus T. Heinz ◽  
Teresa Lenz ◽  
Michaela Döring ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
B Cell ◽  
Pediatric Patients ◽  
Lymphoblastic Leukemia ◽  
Cell Precursor
Sign in / Sign up

Export Citation Format

Share Document